The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
What research is ongoing in patients with ‘incurable’ acute myeloid leukemia?
Gail Roboz
September 30, 2020
During Blood Cancer Awareness Month, Know AML spoke to Gail Roboz, a world-leading doctor in acute myeloid leukemia who is based at Weill Cornell Medicine, New York, US. We asked, "What research or clinical trials are ongoing in patients with currently ‘incurable’ acute myeloid leukemia?". In this video, Gail explains what is meant by 'incurable' acute myeloid leukemia, and how these patients might be ideal candidates for clinical trials if they are physically well enough.
You can find additional patient journey resources via our interactive graphic page.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.
